| 1 |
34356864 | IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications? | 2021 Jul 10 |
1 |
| 2 |
32859092 | Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias. | 2020 Aug 26 |
3 |
| 3 |
31068457 | Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer. | 2019 Aug |
1 |
| 4 |
31564968 | Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatment. | 2019 |
2 |
| 5 |
27819678 | TET2 binds the androgen receptor and loss is associated with prostate cancer. | 2017 Apr |
1 |
| 6 |
27049945 | Reductive carboxylation supports redox homeostasis during anchorage-independent growth. | 2016 Apr 14 |
1 |
| 7 |
27125548 | IDH1-Driven Reductive Carboxylation Supports Anchorage Independence. | 2016 Jun |
1 |
| 8 |
24755473 | IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. | 2014 Jun 15 |
1 |
| 9 |
24857658 | Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. | 2014 Jun 12 |
1 |
| 10 |
23456655 | GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients. | 2013 May |
1 |
| 11 |
23504317 | Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle. | 2013 May 3 |
1 |
| 12 |
23876293 | Knockdown of both mitochondrial isocitrate dehydrogenase enzymes in pancreatic beta cells inhibits insulin secretion. | 2013 Nov |
2 |
| 13 |
22080945 | Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2. | 2012 Jan |
1 |
| 14 |
19246647 | IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. | 2009 Apr |
1 |